Ana Catarina Fonseca
From Wikipedia, the free encyclopedia
Ana Catarina Fonseca | |
|---|---|
 Ana Catarina Fonseca in 2021 | |
| Born | 22 April 1981 |
| Occupation | Neurologist |
| Known for | Research into strokes; precision medicine |
Ana Catarina Fonseca is a Portuguese neurologist, researcher and university teacher.
Ana Catarina Gaspar Fonseca was born on 22 April 1981. She obtained a degree in medicine from the NOVA University Lisbon in Portugal between 1998 and 2004, followed by a master's in neurosciences from the Faculty of Medicine of the University of Lisbon (2007-09). She also obtained a master's in stroke medicine from Danube University Krems in Austria, between 2008 and 2011. She studied at the Harvard T.H. Chan School of Public Health, obtaining a master's in Public Health in 2014 and in the same year completed a PhD in medicine, specialising in neurology, from the University of Lisbon.[1][2][3][4]
Career
Fonseca has been a research fellow at the John Radcliffe Hospital in Oxford, United Kingdom and at the Sainte-Anne Hospital Centre in Paris. She was a resident in the Hospital de Santa Maria in Lisbon and in 2012 became the staff neurologist in the stroke unit at the same hospital. She is a researcher at the Instituto de Medicina Molecular where she manages the stroke biobank collection. She teaches pharmacology and neurology at the University of Lisbon. From 2017 to 2019 Fonseca was vice-president of the Portuguese Neurological Society and she was a member of the Education Committee of the European Stroke Organization. Her main research interests are cryptogenic stroke, heart-brain interactions (cerebrovascular disease), and precision medicine.[1][2][3][4][5]
In addition to having herself published extensively, Fonseca is also an ad hoc external reviewer for a wide range of journals, including the Journal of Neurology, Neurosurgery, and Psychiatry, Stroke, Circulation, Neurology, European Journal of Neurology, Journal of the Neurological Sciences, Acta Neurologica Scandinavica, Journal of Stroke and Cerebrovascular Diseases, European Neurology, International Journal of Stroke Research, JAMA Neurology, and The Lancet.[1]
